Feasibility of dried blood spots for HIV viral load monitoring in decentralized area in North Vietnam in a test-and-treat era, the MOVIDA project

Tuan Anh Nguyen, Tram Hong Tran, Binh Thanh Nguyen, Tram Thi Phuong Pham, Nhung Thi Hong Le, Dung Viet Ta, Huong Thi Thu Phan, Long Hoang Nguyen, Mohand Ait-Ahmed, Hien Thi Ho, Fabien Taieb, Yoann Madec, MOVIDA 2 study group, Tuan Anh Nguyen, Tram Hong Tran, Binh Thanh Nguyen, Tram Thi Phuong Pham, Nhung Thi Hong Le, Dung Viet Ta, Huong Thi Thu Phan, Long Hoang Nguyen, Mohand Ait-Ahmed, Hien Thi Ho, Fabien Taieb, Yoann Madec, MOVIDA 2 study group

Abstract

Background: Access to HIV viral load is crucial to efficiently monitor patients on antiretroviral treatment (ART) and prevent HIV drug resistance acquisition. However, in some remote settings, access to viral load monitoring is still complex due to logistical and financial constraints. Use of dried blood spots (DBS) for blood collection could overcome these difficulties. This study aims to describe feasibility and operability of DBS use for routine viral load monitoring.

Methods: From June 2017 to April 2018, HIV-infected adults who initiated ART were enrolled in a prospective cohort in 43 clinical sites across 6 provinces in North Vietnam. Following national guidelines, the first viral load monitoring was planned 6 months after ART initiation. DBS were collected at the clinical site and sent by post to a central laboratory in Hanoi for viral load measurement.

Results: Of the 578 patients enrolled, 537 were still followed 6 months after ART initiation, of which DBS was collected for 397 (73.9%). The median (inter quartile range) delay between DBS collection at site level and reception at the central laboratory was 8 (6-19) days and for 70.0% viral load was measured ≤30 days after blood collection. The proportion of patients with viral load ≥1000 copies/mL at the 6 month evaluation was 15.9% (n = 59). Of these, a DBS was collected again to confirm virological failure in 15 (24.4%) of which virological failure was confirmed in 11 (73.3%).

Conclusion: Delay of DBS transfer to the central laboratory was acceptable and most viral loads were measured in ≤30 days, in-line with routine follow-up. However, the level of DBS coverage and the proportion of patients in failure for whom a confirmatory viral load was available were suboptimal, indicating that integration of viral load monitoring in the field requires, among other things, careful training and strong involvement of the local teams. The proportion of patients experiencing virological failure was in line with other reports; interestingly those who reported being non-adherent and those with a low BMI were more at risk of failure.

Conflict of interest statement

The authors have declared that no competing interests exist.

References

    1. UNAIDS. last accessed: October 16, 2019. 2017.
    1. Son VH, Abdul-Quader A, Suthar AB. Using strategic information for action: lessons from the HIV/AIDS response in Vietnam. BMJ Glob Health. 2018;3(5):e000793 10.1136/bmjgh-2018-000793
    1. WHO. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection, second edition - (last accessed: October 17, 2019). 2016.
    1. UNAIDS. 90-90-90: An ambitious treatment target to help end the AIDS epidemic (available at: ; last accessed: October 17, 2019). 2014.
    1. HIV and AIDS data hub for Asia Pacific (available at: ; last accessed: April 11, 2019). 2017.
    1. Le NK, Riggi E, Marrone G, Vu TV, Izurieta RO, Nguyen CKT, et al. Assessment of WHO criteria for identifying ART treatment failure in Vietnam from 2007 to 2011. PloS one. 2017;12(9):e0182688 10.1371/journal.pone.0182688
    1. Rawizza HE, Chaplin B, Meloni ST, Eisen G, Rao T, Sankale JL, et al. Immunologic criteria are poor predictors of virologic outcome: implications for HIV treatment monitoring in resource-limited settings. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 2011;53(12):1283–90.
    1. Mee P, Fielding KL, Charalambous S, Churchyard GJ, Grant AD. Evaluation of the WHO criteria for antiretroviral treatment failure among adults in South Africa. Aids. 2008;22(15):1971–7. 10.1097/QAD.0b013e32830e4cd8
    1. Monleau M, Aghokeng AF, Eymard-Duvernay S, Dagnra A, Kania D, Ngo-Giang-Huong N, et al. Field evaluation of dried blood spots for routine HIV-1 viral load and drug resistance monitoring in patients receiving antiretroviral therapy in Africa and Asia. J Clin Microbiol. 2014;52(2):578–86. 10.1128/JCM.02860-13
    1. Rutstein SE, Kamwendo D, Lugali L, Thengolose I, Tegha G, Fiscus SA, et al. Measures of viral load using Abbott RealTime HIV-1 Assay on venous and fingerstick dried blood spots from provider-collected specimens in Malawian District Hospitals. J Clin Virol. 2014;60(4):392–8. 10.1016/j.jcv.2014.05.005
    1. Schmitz ME, Agolory S, Junghae M, Broyles LN, Kimeu M, Ombayo J, et al. Field Evaluation of Dried Blood Spots for HIV-1 Viral Load Monitoring in Adults and Children Receiving Antiretroviral Treatment in Kenya: Implications for Scale-up in Resource-Limited Settings. Journal of acquired immune deficiency syndromes. 2017;74(4):399–406. 10.1097/QAI.0000000000001275
    1. Zeh C, Ndiege K, Inzaule S, Achieng R, Williamson J, Chih-Wei Chang J, et al. Evaluation of the performance of Abbott m2000 and Roche COBAS Ampliprep/COBAS Taqman assays for HIV-1 viral load determination using dried blood spots and dried plasma spots in Kenya. PloS one. 2017;12(6):e0179316 10.1371/journal.pone.0179316
    1. Taieb F TH, Ho TH, et al. Evaluation of Two Techniques for Viral Load Monitoring Using Dried Blood Spot in Routine Practice in Vietnam (French National Agency for AIDS and Hepatitis Research 12338). Open Forum Infectious Diseases. 2016.
    1. Taieb F, Tran Hong T, Ho HT, Nguyen Thanh B, Pham Phuong T, Viet Ta D, et al. First field evaluation of the optimized CE marked Abbott protocol for HIV RNA testing on dried blood spot in a routine clinical setting in Vietnam. PloS one. 2018;13(2):e0191920 10.1371/journal.pone.0191920
    1. Peter T, Ellenberger D, Kim AA, Boeras D, Messele T, Roberts T, et al. Early antiretroviral therapy initiation: access and equity of viral load testing for HIV treatment monitoring. Lancet Infect Dis. 2017;17(1):e26–e9. 10.1016/S1473-3099(16)30212-2
    1. Roberts T, Cohn J, Bonner K, Hargreaves S. Scale-up of Routine Viral Load Testing in Resource-Poor Settings: Current and Future Implementation Challenges. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 2016;62(8):1043–8.
    1. Boillot F, Serrano L, Muwonga J, Kabuayi JP, Kambale A, Mutaka F, et al. Implementation and Operational Research: Programmatic Feasibility of Dried Blood Spots for the Virological Follow-up of Patients on Antiretroviral Treatment in Nord Kivu, Democratic Republic of the Congo. Journal of acquired immune deficiency syndromes. 2016;71(1):e9–15. 10.1097/QAI.0000000000000844
    1. Médecins Sans Frontières. Making viral load routine—Successes and challenges in the implementation of routine HIV viral load monitoring (available at: ; last accessed: April 5, 2019). 2016.
    1. Rutstein SE, Hosseinipour MC, Kamwendo D, Soko A, Mkandawire M, Biddle AK, et al. Dried blood spots for viral load monitoring in Malawi: feasible and effective. PloS one. 2015;10(4):e0124748 10.1371/journal.pone.0124748
    1. Rutstein SE, Golin CE, Wheeler SB, Kamwendo D, Hosseinipour MC, Weinberger M, et al. On the front line of HIV virological monitoring: barriers and facilitators from a provider perspective in resource-limited settings. AIDS Care. 2016;28(1):1–10. 10.1080/09540121.2015.1058896
    1. Tran BX, Nguyen NP. Patient satisfaction with HIV/AIDS care and treatment in the decentralization of services delivery in Vietnam. PloS one. 2012;7(10):e46680 10.1371/journal.pone.0046680
    1. Tran BX, Dang AK, Truong NT, Ha GH, Nguyen HLT, Do HN, et al. Depression and Quality of Life among Patients Living with HIV/AIDS in the Era of Universal Treatment Access in Vietnam. Int J Environ Res Public Health. 2018;15(12).
    1. Dat VQ, Duong BD, Nhan DT, Hai NH, Anh NTL, Thu HHK, et al. Viral load suppression and acquired HIV drug resistance in adults receiving antiretroviral therapy in Viet Nam: results from a nationally representative survey. Western Pac Surveill Response J. 2018;9(3):16–24. 10.5365/wpsar.2018.9.1.008
    1. Tanuma J, Matsumoto S, Haneuse S, Cuong DD, Vu TV, Thuy PTT, et al. Long-term viral suppression and immune recovery during first-line antiretroviral therapy: a study of an HIV-infected adult cohort in Hanoi, Vietnam. Journal of the International AIDS Society. 2017;20(4).
    1. Auld AF, Shiraishi RW, Mbofana F, Couto A, Fetogang EB, El-Halabi S, et al. Lower Levels of Antiretroviral Therapy Enrollment Among Men with HIV Compared with Women—12 Countries, 2002–2013. MMWR Morb Mortal Wkly Rep. 2015;64(46):1281–6. 10.15585/mmwr.mm6446a2
    1. Tran DA, Shakeshaft A, Ngo AD, Mallitt KA, Wilson D, Doran C, et al. Determinants of antiretroviral therapy initiation and treatment outcomes for people living with HIV in Vietnam. HIV Clin Trials. 2013;14(1):21–33. 10.1410/hct1401-21
    1. Lan CW, Lin C, Thanh DC, Li L. Drug-related stigma and access to care among people who inject drugs in Vietnam. Drug Alcohol Rev. 2018;37(3):333–9. 10.1111/dar.12589
    1. Nguyen TA, Oosterhoff P, Hardon A, Tran HN, Coutinho RA, Wright P. A hidden HIV epidemic among women in Vietnam. BMC Public Health. 2008;8:37 10.1186/1471-2458-8-37
    1. Nguyen HH, Bui DD, Dinh TT, Pham LQ, Nguyen VT, Tran TH, et al. A prospective "test-and-treat" demonstration project among people who inject drugs in Vietnam. Journal of the International AIDS Society. 2018;21(7):e25151 10.1002/jia2.25151
    1. IeDea Collaborations CC. Global Trends in CD4 Cell Count at the Start of Antiretroviral Therapy: Collaborative Study of Treatment Programs. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 2018;66(6):893–903.
    1. Rangarajan S, Donn JC, Giang le T, Bui DD, Hung Nguyen H, Tou PB, et al. Factors associated with HIV viral load suppression on antiretroviral therapy in Vietnam. J Virus Erad. 2016;2(2):94–101.
    1. Madec Y, Laureillard D, Pinoges L, Fernandez M, Prak N, Ngeth C, et al. Response to highly active antiretroviral therapy among severely immuno-compromised HIV-infected patients in Cambodia. Aids. 2007;21(3):351–9. 10.1097/QAD.0b013e328012c54f
    1. Naidoo K, Yende-Zuma N, Augustine S. A retrospective cohort study of body mass index and survival in HIV infected patients with and without TB co-infection. Infect Dis Poverty. 2018;7(1):35 10.1186/s40249-018-0418-3
    1. Mwau M, Syeunda CA, Adhiambo M, Bwana P, Kithinji L, Mwende J, et al. Scale-up of Kenya's national HIV viral load program: Findings and lessons learned. PloS one. 2018;13(1):e0190659 10.1371/journal.pone.0190659
    1. Free Virus Elution Protocol for HIV Viral Load Testing from DBS on Roche cobas® AmpliPrep/cobas® TaqMan HIV-1 Test v2.0. Available at . Accessed on january 2016
    1. Etoori D, Ciglenecki I, Ndlangamandla M, Edwards CG, Jobanputra K, Pasipamire M, et al. Successes and challenges in optimizing the viral load cascade to improve antiretroviral therapy adherence and rationalize second-line switches in Swaziland. Journal of the International AIDS Society. 2018;21(10):e25194 10.1002/jia2.25194
    1. Monleau M, Montavon C, Laurent C, Segondy M, Montes B, Delaporte E, et al. Evaluation of different RNA extraction methods and storage conditions of dried plasma or blood spots for human immunodeficiency virus type 1 RNA quantification and PCR amplification for drug resistance testing. J Clin Microbiol. 2009;47(4):1107–18. 10.1128/JCM.02255-08

Source: PubMed

Sponsoren und Mitarbeiter

Krankheiten

Drogeninterventionen

3
Abonnieren